PGxAI, a company advancing the intersection of pharmacogenomics and artificial intelligence, announced today that Roni Zeiger, MD, has joined as Product Strategy Advisor. The appointment underscores the company’s mission to accelerate innovation in AI-driven health solutions and expand its impact across both clinical and consumer health applications.
Health-Tech Expertise from Google and Meta
Dr. Zeiger brings extensive leadership experience in digital health. He previously served as Head of Health Strategy at Meta and as Chief Health Strategist at Google, where he spearheaded initiatives to broaden access to healthcare, leverage data-driven insights, and enhance patient engagement.
Advancing Precision Medicine with AI
At PGxAI, Zeiger will advise on strategies to integrate AI insights with genomic data to improve medication personalization, clinical decision-making, and consumer-friendly health applications. The company’s platform uses AI to analyze genetic markers and predict individual responses to medications, helping make pharmacogenomics more practical and accessible for providers and patients.
“Roni’s expertise in shaping health technology ecosystems will be invaluable as we expand the impact of AI in precision medicine,” said a PGxAI spokesperson. “His vision aligns with our mission to make pharmacogenomic insights scalable and meaningful for everyday healthcare.”
Positioning for Growth in AI-Driven Healthcare
Zeiger’s appointment comes as the healthcare industry experiences rapid growth in AI-powered genomics and precision medicine. By bringing on an advisor with global health-tech leadership credentials, PGxAI signals its intent to bridge the gap between advanced science and real-world clinical practice, setting the stage for broader adoption of pharmacogenomic tools worldwide.
